401k Plan data: ADMA BIOLOGICS, INC. 401(K) PLAN plan

ADMA BIOLOGICS, INC. 401(K) PLAN 401k Plan overview

Plan Name	ADMA BIOLOGICS, INC. 401(K) PLAN
Plan identification number	001

ADMA BIOLOGICS, INC. 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

ADMA BIOLOGICS, INC. has sponsored the creation of one or more 401k plans.

Company Name: ADMA BIOLOGICS, INC.

Employer identification number (EIN): 562590442

NAIC Classification: 325410

Form 5500 Filing Information

Submission information for form 5500 for 401k plan ADMA BIOLOGICS, INC. 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 MAUREEN GARRITY 2018-07-27
001 2016-01-01 FANNY ORTEGA 2017-06-07
001 2015-01-01 FANNY ORTEGA 2016-07-12
001 2014-01-01 FANNY ORTEGA 2015-07-14

Plan Statistics for ADMA BIOLOGICS, INC. 401(K) PLAN

401k plan membership statisitcs for ADMA BIOLOGICS, INC. 401(K) PLAN

Measure Date Value
2022: ADMA BIOLOGICS, INC. 401(K) PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 593
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 596
Number of retired or separated participants receiving benefits 2022-01-01 2
Number of other retired or separated participants entitled to future benefits 2022-01-01 87
Total of all active and inactive participants 2022-01-01 685
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 1
Total participants 2022-01-01 686
Number of participants with account balances 2022-01-01 412
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: ADMA BIOLOGICS, INC. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 468
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 498
Number of retired or separated participants receiving benefits 2021-01-01 2
Number of other retired or separated participants entitled to future benefits 2021-01-01 90
Total of all active and inactive participants 2021-01-01 590
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 1
Total participants 2021-01-01 591
Number of participants with account balances 2021-01-01 393
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: ADMA BIOLOGICS, INC. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 373
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 397
Number of retired or separated participants receiving benefits 2020-01-01 1
Number of other retired or separated participants entitled to future benefits 2020-01-01 66
Total of all active and inactive participants 2020-01-01 464
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 2
Total participants 2020-01-01 466
Number of participants with account balances 2020-01-01 308
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: ADMA BIOLOGICS, INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 317
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 306
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 67
Total of all active and inactive participants 2019-01-01 373
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 373
Number of participants with account balances 2019-01-01 284
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: ADMA BIOLOGICS, INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 286
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 246
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 69
Total of all active and inactive participants 2018-01-01 315
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 1
Total participants 2018-01-01 316
Number of participants with account balances 2018-01-01 250
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 1

Measure	Date	Value
2022: ADMA BIOLOGICS, INC. 401(K) PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	593
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	596
Number of retired or separated participants receiving benefits	2022-01-01	2
Number of other retired or separated participants entitled to future benefits	2022-01-01	87
Total of all active and inactive participants	2022-01-01	685
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	1
Total participants	2022-01-01	686
Number of participants with account balances	2022-01-01	412
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: ADMA BIOLOGICS, INC. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	468
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	498
Number of retired or separated participants receiving benefits	2021-01-01	2
Number of other retired or separated participants entitled to future benefits	2021-01-01	90
Total of all active and inactive participants	2021-01-01	590
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	1
Total participants	2021-01-01	591
Number of participants with account balances	2021-01-01	393
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: ADMA BIOLOGICS, INC. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	373
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	397
Number of retired or separated participants receiving benefits	2020-01-01	1
Number of other retired or separated participants entitled to future benefits	2020-01-01	66
Total of all active and inactive participants	2020-01-01	464
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	2
Total participants	2020-01-01	466
Number of participants with account balances	2020-01-01	308
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: ADMA BIOLOGICS, INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	317
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	306
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	67
Total of all active and inactive participants	2019-01-01	373
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	373
Number of participants with account balances	2019-01-01	284
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: ADMA BIOLOGICS, INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	286
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	246
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	69
Total of all active and inactive participants	2018-01-01	315
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	1
Total participants	2018-01-01	316
Number of participants with account balances	2018-01-01	250
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	1

Financial Data on ADMA BIOLOGICS, INC. 401(K) PLAN

Measure	Date	Value
2022 : ADMA BIOLOGICS, INC. 401(K) PLAN 2022 401k financial data
Total income from all sources (including contributions)	2022-12-31	$932,263
Total of all expenses incurred	2022-12-31	$1,540,714
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$1,402,823
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$4,561,284
Value of total assets at end of year	2022-12-31	$20,746,936
Value of total assets at beginning of year	2022-12-31	$21,355,387
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$137,891
Total interest from all sources	2022-12-31	$44,016
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$364,187
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$364,187
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$2,419,826
Participant contributions at end of year	2022-12-31	$732,404
Participant contributions at beginning of year	2022-12-31	$559,782
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$828,790
Value of other receiveables (less allowance for doubtful accounts) at end of year	2022-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2022-12-31	$0
Administrative expenses (other) incurred	2022-12-31	$137,891
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-608,451
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$20,746,936
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$21,355,387
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$18,334,646
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$19,674,938
Interest on participant loans	2022-12-31	$34,922
Interest earned on other investments	2022-12-31	$9,094
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$1,668,591
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$1,100,951
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-4,037,224
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$1,312,668
Employer contributions (assets) at end of year	2022-12-31	$11,295
Employer contributions (assets) at beginning of year	2022-12-31	$19,716
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$1,402,823
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2022-12-31	No
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	COHNREZNICK LLP
Accountancy firm EIN	2022-12-31	221478099
2021 : ADMA BIOLOGICS, INC. 401(K) PLAN 2021 401k financial data
Total income from all sources (including contributions)	2021-12-31	$6,567,379
Total of all expenses incurred	2021-12-31	$2,351,419
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$2,222,948
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$3,690,734
Value of total assets at end of year	2021-12-31	$21,355,387
Value of total assets at beginning of year	2021-12-31	$17,139,427
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$128,471
Total interest from all sources	2021-12-31	$44,552
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$397,935
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$397,935
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$2,069,118
Participant contributions at end of year	2021-12-31	$559,782
Participant contributions at beginning of year	2021-12-31	$580,274
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$480,779
Value of other receiveables (less allowance for doubtful accounts) at end of year	2021-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2021-12-31	$0
Administrative expenses (other) incurred	2021-12-31	$128,471
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$4,215,960
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$21,355,387
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$17,139,427
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$19,674,938
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$15,261,925
Interest on participant loans	2021-12-31	$32,492
Interest earned on other investments	2021-12-31	$12,060
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$1,100,951
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$1,268,157
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$2,434,158
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$1,140,837
Employer contributions (assets) at end of year	2021-12-31	$19,716
Employer contributions (assets) at beginning of year	2021-12-31	$29,071
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$2,222,948
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2021-12-31	No
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	COHNREZNICK LLP
Accountancy firm EIN	2021-12-31	221478099
2020 : ADMA BIOLOGICS, INC. 401(K) PLAN 2020 401k financial data
Total income from all sources (including contributions)	2020-12-31	$5,299,483
Total of all expenses incurred	2020-12-31	$1,200,384
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$1,106,263
Value of total corrective distributions	2020-12-31	$2,065
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$3,049,067
Value of total assets at end of year	2020-12-31	$17,139,427
Value of total assets at beginning of year	2020-12-31	$13,040,328
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$92,056
Total interest from all sources	2020-12-31	$27,867
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$253,532
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$253,532
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$1,667,105
Participant contributions at end of year	2020-12-31	$580,274
Participant contributions at beginning of year	2020-12-31	$487,786
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$464,343
Administrative expenses (other) incurred	2020-12-31	$92,056
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$4,099,099
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$17,139,427
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$13,040,328
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$15,261,925
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$12,353,621
Interest on participant loans	2020-12-31	$27,867
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$1,268,157
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$180,516
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$1,969,017
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$917,619
Employer contributions (assets) at end of year	2020-12-31	$29,071
Employer contributions (assets) at beginning of year	2020-12-31	$18,405
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$1,106,263
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2020-12-31	No
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Unqualified
Accountancy firm name	2020-12-31	COHNREZNICK LLP
Accountancy firm EIN	2020-12-31	221478099
2019 : ADMA BIOLOGICS, INC. 401(K) PLAN 2019 401k financial data
Total income from all sources (including contributions)	2019-12-31	$4,911,095
Total income from all sources (including contributions)	2019-12-31	$4,911,095
Total of all expenses incurred	2019-12-31	$1,003,567
Total of all expenses incurred	2019-12-31	$1,003,567
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$928,035
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$928,035
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$2,646,103
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$2,646,103
Value of total assets at end of year	2019-12-31	$13,040,328
Value of total assets at end of year	2019-12-31	$13,040,328
Value of total assets at beginning of year	2019-12-31	$9,132,800
Value of total assets at beginning of year	2019-12-31	$9,132,800
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$75,532
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$75,532
Total interest from all sources	2019-12-31	$21,853
Total interest from all sources	2019-12-31	$21,853
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$253,558
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$253,558
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$253,558
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$253,558
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$1,412,400
Contributions received from participants	2019-12-31	$1,412,400
Participant contributions at end of year	2019-12-31	$487,786
Participant contributions at end of year	2019-12-31	$487,786
Participant contributions at beginning of year	2019-12-31	$304,201
Participant contributions at beginning of year	2019-12-31	$304,201
Participant contributions at end of year	2019-12-31	$0
Participant contributions at end of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$50,050
Participant contributions at beginning of year	2019-12-31	$50,050
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$511,350
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$511,350
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$0
Administrative expenses (other) incurred	2019-12-31	$75,532
Administrative expenses (other) incurred	2019-12-31	$75,532
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$3,907,528
Value of net income/loss	2019-12-31	$3,907,528
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$13,040,328
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$13,040,328
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$9,132,800
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$9,132,800
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$12,353,621
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$12,353,621
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$8,352,502
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$8,352,502
Interest on participant loans	2019-12-31	$21,853
Interest on participant loans	2019-12-31	$21,853
Interest earned on other investments	2019-12-31	$0
Interest earned on other investments	2019-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$180,516
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$180,516
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$374,248
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$374,248
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$1,989,581
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$1,989,581
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$722,353
Contributions received in cash from employer	2019-12-31	$722,353
Employer contributions (assets) at end of year	2019-12-31	$18,405
Employer contributions (assets) at end of year	2019-12-31	$18,405
Employer contributions (assets) at beginning of year	2019-12-31	$51,799
Employer contributions (assets) at beginning of year	2019-12-31	$51,799
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$928,035
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$928,035
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-12-31	No
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-12-31	No
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	COHNREZNICK LLP
Accountancy firm name	2019-12-31	COHNREZNICK LLP
Accountancy firm EIN	2019-12-31	221478099
Accountancy firm EIN	2019-12-31	221478099
2018 : ADMA BIOLOGICS, INC. 401(K) PLAN 2018 401k financial data
Total transfer of assets to this plan	2018-12-31	$2,692,136
Total income from all sources (including contributions)	2018-12-31	$2,152,753
Total of all expenses incurred	2018-12-31	$1,098,978
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$1,026,534
Expenses. Certain deemed distributions of participant loans	2018-12-31	$18
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$2,807,134
Value of total assets at end of year	2018-12-31	$9,132,800
Value of total assets at beginning of year	2018-12-31	$5,386,889
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$72,426
Total interest from all sources	2018-12-31	$13,533
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$212,826
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$212,826
Was this plan covered by a fidelity bond	2018-12-31	No
If this is an individual account plan, was there a blackout period	2018-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$1,512,152
Participant contributions at end of year	2018-12-31	$304,201
Participant contributions at beginning of year	2018-12-31	$123,467
Participant contributions at end of year	2018-12-31	$50,050
Participant contributions at beginning of year	2018-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$525,175
Value of other receiveables (less allowance for doubtful accounts) at end of year	2018-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2018-12-31	$0
Administrative expenses (other) incurred	2018-12-31	$72,426
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$1,053,775
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$9,132,800
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$5,386,889
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$8,352,502
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$0
Interest on participant loans	2018-12-31	$13,533
Interest earned on other investments	2018-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2018-12-31	$374,248
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2018-12-31	$5,263,422
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-880,740
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$769,807
Employer contributions (assets) at end of year	2018-12-31	$51,799
Employer contributions (assets) at beginning of year	2018-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$1,026,534
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	Yes
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	COHNREZNICK LLP
Accountancy firm EIN	2018-12-31	221478099

Form 5500 Responses for ADMA BIOLOGICS, INC. 401(K) PLAN

2022: ADMA BIOLOGICS, INC. 401(K) PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: ADMA BIOLOGICS, INC. 401(K) PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: ADMA BIOLOGICS, INC. 401(K) PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: ADMA BIOLOGICS, INC. 401(K) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: ADMA BIOLOGICS, INC. 401(K) PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement – Insurance	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )

Policy contract number

513148

Policy instance

Insurance contract or identification number	513148
Number of Individuals Covered	412
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $3,790
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $3,790
Insurance broker organization code?	3

TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )

Policy contract number

513148

Policy instance

Insurance contract or identification number	513148
Number of Individuals Covered	393
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $4,474
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $4,474
Insurance broker organization code?	3

TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )

Policy contract number

513148

Policy instance

Insurance contract or identification number	513148
Number of Individuals Covered	308
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $2,469
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $2,469
Insurance broker organization code?	3

TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )

Policy contract number

513148

Policy instance

Insurance contract or identification number	513148
Number of Individuals Covered	284
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $842
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $842
Insurance broker organization code?	3

TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )

Policy contract number

513148

Policy instance

Insurance contract or identification number	513148
Number of Individuals Covered	250
Insurance policy start date	2019-03-28
Insurance policy end date	2019-12-31
Total amount of commissions paid to insurance broker	USD $573
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $573
Insurance broker organization code?	3

Potentially related plans

ADMA BIOLOGICS, INC. 401(K) PLAN [EIN = 371851419]

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	ADMA BIOLOGICS, INC.
Employer identification number (EIN):	562590442
NAIC Classification:	325410